$ENVA

GOODYEAR WILLIAM M sold $658K of ENVA

GOODYEAR WILLIAM M sold 3,500 shares of Enova International, Inc. (ENVA) at $188.02 ($0.66M total) on 2026-06-16.

Original reporting
SEC EDGAR · GOODYEAR WILLIAM M
Published Jun 16, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ENVA
Neutral
high confidence
Mentioned
$ENVA
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

A director open-market sale can slightly pressure sentiment, but without additional company news it is unlikely to drive sustained repricing.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it lacks a fundamental catalyst in the provided text.

03

What to watch

The text does not state whether the director’s remaining holdings are large relative to prior sales, nor does it provide context for why the sale occurred.

Relevance 5/10Novelty 6/10Timing: filed 2026-06-16 (same day as sale)

Background

The article is an SEC Form 4 insider transaction disclosure for Enova International, Inc.

Company-level read

Ticker impact

$ENVANeutralHigh confidence
Context

Enova International director William M Goodyear sold 3,500 shares in an open-market transaction at $188.0157 on 2026-06-16.

Expected impact

Likely limited near-term impact; any effect should fade unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is a routine insider sale with no 10b5-1 plan and no accompanying operational/regulatory development in the text.

Market effects

No sector-level read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may be liquidity-driven (taxes/diversification) and not a bearish signal, especially without any other negative company-specific information.

Key entities

  • Enova International, Inc.

    Subject of the Form 4 insider transaction; director sold 3,500 shares at $188.0157.

  • GOODYEAR WILLIAM M

    Director who executed the open-market sale; holdings after transaction: 50,820 shares.

Related articles

$OPFIMed

OppFi and Enova Bank Deals Put Lending Under Scrutiny

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

$ENVAMed

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (NYSE: ENVA) shares rose about 9% after Q2 results and guidance-related optimism. The company reported adjusted EPS of $4.31 vs $3.96 consensus and revenue of $928.9M vs $764M prior year, with operating cash flow of $544M and $531.4M free cash flow. Analysts reportedly raised price targets to $257-$280, citing the Grasshopper Bank acquisition and improving credit metrics.

$ENVAMedAI 8/10

Enova International Stock Jumps After Powerful Q2 Beat

Enova International Inc. (NYSE: ENVA) shares rose about 9% during the week after the company reported Q2 2026 results and raised guidance. Adjusted EPS was $4.31 versus $3.96 expected, with revenue up to $928.9M from $764M. Management cited record $5.5B loans, improving margins, and ongoing share repurchases.

$ENVAMed

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

Enova International Inc. (NYSE: ENVA) shares rose about 9% after its Q2 2026 results. The company reported adjusted EPS of $4.31 versus $3.23 a year earlier and revenue of $928.9M versus $764M, alongside a consumer credit outlook. Analysts cited bullish targets of $257 to $280 and support near $230.

$ENVAMedAI 8/10

Enova International Signals Strong Growth and Rising EPS

Enova International (ENVA) reported Q2 results and said consolidated originations rose 27% YoY to nearly $2.3B and total revenue rose 22% to $929M. Adjusted EPS increased 33% YoY to $4.31. Credit metrics improved, with net charge-offs at 7.3%. Management raised Q3 and 2026 guidance and noted the pending Grasshopper Bank deal awaits regulatory approval.

$ENVAMedAI 8/10

Enova Reports Second Quarter 2026 Results

Enova International (NYSE: ENVA) reported Q2 2026 results. Total revenue rose 22% to $929 million. Diluted EPS was $4.00, up 40%, and adjusted EPS was $4.31, up 33%. Credit metrics stayed strong, with net charge-offs at a 7.3% ratio and net revenue margin at 61%. Enova also repurchased $19 million of stock and reported $929 million liquidity at June 30.